S. Galieguezouitina et al., MOLECULAR-CLONING OF A T(11-14)(Q13-Q32) TRANSLOCATION BREAKPOINT CENTROMERIC TO THE BCL1-MTC, Genes, chromosomes & cancer, 11(4), 1994, pp. 246-255
In B-cell malignancies, the (11;14)(q13;q32) at the 11q13 BCL1 locus i
s characterized by a scattering of breakpoint sites along a 100 kb gen
omic region, between the BCL1 major translocation cluster (MTC) and th
e PRAD1 (also termed cyclin D1 or CCND1) gene. Recently, the 11q13 bre
akpoint region was extended on both sides, centromeric to the MTC and
telomeric to PRAD1. We report here the molecular cloning of a new t(11
;14) breakpoint site, 20 kb centromeric to the MTC, from a patient wit
h prolymphocytic leukemia. We subcloned a non-repetitive DNA fragment
near the breakpoint and mapped this new 11q13 probe (pHO11(c)) relativ
e to already identified breakpoint sites, using long- and short-range
physical mapping within the BCL1 locus. Rearrangements in the BCL1 loc
us are associated with deregulation of the PRAD1 gene, which is often
overexpressed, particularly in mantle-cell malignancies. The detectabl
e but weak PRAD1 expression in the case we present suggests that this
breakpoint centromeric to the MTC still lies inside the BCL1 locus bou
ndaries. We think that attention should be focused on this region cent
romeric to the BCL1-MTC, where the investigation of previously unident
ified translocations may increase understanding of the PRAD1 gene dere
gulation in t( 11;14) associated pathologies. (C) 1994 Wiley-Liss, Inc
.